References
- Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153(1):162–166. doi:10.1016/j.ajo.2011.06.020.
- Sahu C, Kumar K, Sinha MK, Venkata A, Majji AB, Jalali S. Review of endogenous endophthalmitis during pregnancy including case series. Int Ophthalmol. 2013;33:611–618. doi:10.1007/s10792-012-9697-z.
- Lee JH, Kim JS, Park YH. Diagnosis and treatment of postpartum Candida endophthalmitis. J Obstet Gynaecol Res. 2012;38(9):1220–1222. doi:10.1111/j.1447-0756.2012.01854.x.
- Tsai CC, Chen SJ, Chung YM, Yu KW, Hsu WM. Postpartum endogenous candida endophthalmitis. J Formos Med Assoc. 2002;101:432–436.
- Wu JS, Chen SN, Hwang JF, Lin CJ. Endogenous mycotic endophthalmitis in an immunocompetent postpartum patient. Retin Cases Brief Rep. 2011;5:10–13. doi:10.1097/ICB.0b013e3181bcf389.
- AlBloushi AF, Almousa AN, Alkheraiji NF, Abu El-Asrar AM. Postpartum endogenous Candida endophthalmitis. Middle East Afr J Ophthalmol. 2019;26(2):110–113. doi:10.4103/meajo.MEAJO_284_18.
- Sharma M, Solanki A. Prevalence of Candida infection in pregnant women with and without diabetes. Int J Curr Microbiol Ap Sci. 2014;3(4):605–610.
- Kreger-van Rij NJ. Candida ciferrii, a new yeast species. Mycopathol Mycol Appl. 1965;26(1):49–52. doi:10.1007/BF02098589.
- Gentile LD, Bouchara JP, Cimon B, Chabasse D. Candida ciferrii: clinical and microbiological features of an emerging pathogen. Mycoses. 1991;34:125–128. doi:10.1111/j.1439-0507.1991.tb00632.x.
- Gunsilius E, Lass-Florl C, Kahler CM, Gastl G, Petzer AL. Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol. 2001;80(3):178–179. doi:10.1007/s002770000252.
- Soki H, Abo K, Yamazaki K, Kojima T, Oda T, Uzawa Y. First report of intraorbital abscess caused by Candida allociferrii and specific PCR for differentiating Stephanoascus ciferrii complex species. Med Mycol J. 2015;56(2):E9–14. doi:10.3314/mmj.56.E9.
- Danielescu C, Cantemir A, Dorin C. Successful treatment of fungal endophthalmitis using intravitreal caspofungin. Arq Bras Oftalmol. 2017;80(3):196–198. doi:10.5935/0004-2749.20170048.
- Dave V, Sharma S, Dave P, Joseph J, Clinical Presentations PR, Dilemma D. And management outcomes of chronic postoperative endophthalmitis caused by Stephanoascus ciferrii. Retina Cases Brief Rep. 2021 1;15(3):269–274. doi:10.1097/ICB.0000000000000782.
- Khan FA, Slain D, Khakoo RA. Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy. 2007;27(12):1711–1721. doi:10.1592/phco.27.12.1711.
- Sallam A, Taylor SR, Khan A, et al. Factors determining visual outcome in endogenous candida endophthalmitis. Retina. 2012;32(6):1129–1134. doi:10.1097/IAE.0b013e31822d3a34.
- Behera UC, Budhwani M, Das T, et al. Of early vitrectomy in the treatment of fungal endophthalmitis. Retina. 2018;38(7):1385–1392. doi:10.1097/IAE.0000000000001727.